nodes	percent_of_prediction	percent_of_DWPC	metapath
Oxyphencyclimine—Hexylcaine—SCN5A—dilated cardiomyopathy	0.226	1	CrCbGaD
Oxyphencyclimine—CHRM1—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0192	0.0248	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.0191	0.0247	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Monoamine GPCRs—ADRB1—dilated cardiomyopathy	0.019	0.0245	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Circadian rythm related genes—SIK1—dilated cardiomyopathy	0.0177	0.0229	CbGpPWpGaD
Oxyphencyclimine—CHRM2—SIDS Susceptibility Pathways—SCN5A—dilated cardiomyopathy	0.0162	0.021	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0161	0.0208	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0161	0.0208	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Amine ligand-binding receptors—ADRB1—dilated cardiomyopathy	0.0159	0.0206	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0156	0.0201	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0155	0.02	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Monoamine GPCRs—ADRB2—dilated cardiomyopathy	0.0154	0.0198	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0131	0.0169	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.013	0.0168	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Amine ligand-binding receptors—ADRB2—dilated cardiomyopathy	0.0129	0.0167	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.0122	0.0157	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.0121	0.0156	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Calcium Regulation in the Cardiac Cell—RYR2—dilated cardiomyopathy	0.012	0.0155	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0118	0.0153	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0118	0.0152	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Calcium Regulation in the Cardiac Cell—PLN—dilated cardiomyopathy	0.0117	0.0151	CbGpPWpGaD
Oxyphencyclimine—CHRM2—SIDS Susceptibility Pathways—RYR2—dilated cardiomyopathy	0.0116	0.0149	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.0098	0.0127	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00977	0.0126	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Class A Rhodopsin-like—MAS1—dilated cardiomyopathy	0.00967	0.0125	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00896	0.0116	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00893	0.0115	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Regulation of Actin Cytoskeleton—VCL—dilated cardiomyopathy	0.00885	0.0114	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00878	0.0113	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Other—CXCR3—dilated cardiomyopathy	0.00869	0.0112	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00689	0.0089	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Other—ADRB2—dilated cardiomyopathy	0.00682	0.00881	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00575	0.00743	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00573	0.0074	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB1—dilated cardiomyopathy	0.00568	0.00733	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00475	0.00613	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00473	0.00611	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Calcium Regulation in the Cardiac Cell—GJA1—dilated cardiomyopathy	0.00468	0.00605	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00466	0.00602	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.00464	0.006	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Calcium Regulation in the Cardiac Cell—ADRB2—dilated cardiomyopathy	0.0046	0.00594	CbGpPWpGaD
Oxyphencyclimine—CHRM2—SIDS Susceptibility Pathways—GJA1—dilated cardiomyopathy	0.00452	0.00583	CbGpPWpGaD
Oxyphencyclimine—CHRM2—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00438	0.00565	CbGpPWpGaD
Oxyphencyclimine—CHRM2—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00438	0.00565	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00412	0.00532	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.0041	0.0053	CbGpPWpGaD
Oxyphencyclimine—CHRM1—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00409	0.00529	CbGpPWpGaD
Oxyphencyclimine—CHRM3—G alpha (q) signalling events—AGTR1—dilated cardiomyopathy	0.00408	0.00527	CbGpPWpGaD
Oxyphencyclimine—CHRM2—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00407	0.00526	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00406	0.00525	CbGpPWpGaD
Oxyphencyclimine—CHRM2—SIDS Susceptibility Pathways—IL10—dilated cardiomyopathy	0.00392	0.00506	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00383	0.00494	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00381	0.00493	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00378	0.00488	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00371	0.00479	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00369	0.00477	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00366	0.00473	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00366	0.00472	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGTR1—dilated cardiomyopathy	0.00365	0.00471	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00362	0.00467	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00361	0.00466	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Regulation of Actin Cytoskeleton—RAC1—dilated cardiomyopathy	0.00357	0.00461	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00353	0.00455	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00353	0.00455	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00352	0.00454	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00352	0.00454	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00348	0.0045	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00348	0.0045	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00328	0.00423	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00327	0.00422	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00324	0.00418	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00318	0.0041	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00316	0.00409	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00316	0.00409	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00315	0.00407	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00313	0.00405	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00312	0.00404	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.003	0.00388	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00299	0.00387	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00296	0.00383	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.0029	0.00375	CbGpPWpGaD
Oxyphencyclimine—CHRM1—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00288	0.00372	CbGpPWpGaD
Oxyphencyclimine—CHRM3—G alpha (q) signalling events—AGT—dilated cardiomyopathy	0.00287	0.00371	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00271	0.0035	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.0027	0.00349	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00269	0.00347	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00269	0.00347	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00268	0.00346	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00268	0.00346	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.00268	0.00346	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.00265	0.00342	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.00265	0.00342	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—ANKRD1—dilated cardiomyopathy	0.00259	0.00335	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00258	0.00333	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00257	0.00332	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—AGT—dilated cardiomyopathy	0.00257	0.00332	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00256	0.00331	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.00254	0.00328	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0025	0.00322	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00249	0.00321	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.00246	0.00318	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—TAZ—dilated cardiomyopathy	0.00244	0.00315	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00242	0.00312	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00241	0.00311	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.0024	0.0031	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00239	0.00309	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.00239	0.00308	CbGpPWpGaD
Oxyphencyclimine—CHRM2—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.00237	0.00306	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Regulation of Actin Cytoskeleton—RAF1—dilated cardiomyopathy	0.00237	0.00306	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—SDHA—dilated cardiomyopathy	0.0022	0.00285	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00206	0.00267	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00206	0.00266	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.00204	0.00263	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00196	0.00253	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00195	0.00252	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00193	0.0025	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00191	0.00246	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.0019	0.00246	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00188	0.00243	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00179	0.00231	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—RAF1—dilated cardiomyopathy	0.00178	0.0023	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00164	0.00212	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00164	0.00212	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Regulation of Actin Cytoskeleton—EGFR—dilated cardiomyopathy	0.00162	0.0021	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00152	0.00196	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00152	0.00196	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.00151	0.00195	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.00151	0.00195	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.0015	0.00193	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.0015	0.00193	CbGpPWpGaD
Oxyphencyclimine—CHRM2—SIDS Susceptibility Pathways—TNF—dilated cardiomyopathy	0.00149	0.00192	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00145	0.00188	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00145	0.00187	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR ligand binding—AGT—dilated cardiomyopathy	0.00143	0.00185	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00141	0.00182	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00141	0.00182	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.00139	0.0018	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00138	0.00178	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00138	0.00178	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00137	0.00177	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00137	0.00177	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00137	0.00176	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00136	0.00176	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.00136	0.00176	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.00136	0.00176	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.00135	0.00174	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00128	0.00165	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00128	0.00165	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.00126	0.00163	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00124	0.0016	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00124	0.0016	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00123	0.00158	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.00122	0.00158	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—dilated cardiomyopathy	0.00122	0.00158	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00117	0.00151	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00116	0.0015	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00115	0.00149	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00111	0.00143	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.0011	0.00143	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00109	0.00141	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00106	0.00137	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00106	0.00136	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00105	0.00135	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.00101	0.0013	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.001	0.00129	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000992	0.00128	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000917	0.00118	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000914	0.00118	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000905	0.00117	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000859	0.00111	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000857	0.00111	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000848	0.0011	CbGpPWpGaD
Oxyphencyclimine—CHRM1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000821	0.00106	CbGpPWpGaD
Oxyphencyclimine—CHRM3—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000819	0.00106	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000814	0.00105	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000814	0.00105	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000811	0.00105	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000811	0.00105	CbGpPWpGaD
Oxyphencyclimine—CHRM2—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000811	0.00105	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000804	0.00104	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000804	0.00104	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00078	0.00101	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000778	0.001	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.00077	0.000995	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000757	0.000977	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000754	0.000974	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000747	0.000965	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000746	0.000963	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000743	0.00096	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000736	0.000951	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000733	0.000947	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000731	0.000944	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000724	0.000934	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000626	0.000808	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000624	0.000806	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000618	0.000798	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—GPX1—dilated cardiomyopathy	0.000599	0.000773	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000594	0.000767	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000592	0.000765	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000586	0.000757	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—CD36—dilated cardiomyopathy	0.000583	0.000753	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Metabolism—AGT—dilated cardiomyopathy	0.000525	0.000678	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000518	0.000668	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000516	0.000666	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000511	0.00066	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00051	0.000659	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000509	0.000657	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000504	0.000651	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000461	0.000595	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RAC1—dilated cardiomyopathy	0.00046	0.000594	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000455	0.000588	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000441	0.000569	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—AGT—dilated cardiomyopathy	0.000439	0.000567	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—AGT—dilated cardiomyopathy	0.000435	0.000562	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000355	0.000458	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000354	0.000457	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.00035	0.000452	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000306	0.000395	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000305	0.000394	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000302	0.00039	CbGpPWpGaD
Oxyphencyclimine—CHRM1—Signaling Pathways—EGFR—dilated cardiomyopathy	0.00021	0.000271	CbGpPWpGaD
Oxyphencyclimine—CHRM3—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000209	0.00027	CbGpPWpGaD
Oxyphencyclimine—CHRM2—Signaling Pathways—EGFR—dilated cardiomyopathy	0.000207	0.000267	CbGpPWpGaD
